Mimedx Group Stock Price on December 19, 2024
MDXG Stock | USD 9.05 0.01 0.11% |
If you're considering investing in MiMedx Stock, it is important to understand the factors that can impact its price. As of today, the current price of MiMedx stands at 9.05, as last reported on the 30th of January, with the highest price reaching 9.30 and the lowest price hitting 8.88 during the day. MiMedx appears to be somewhat reliable, given 3 months investment horizon. MiMedx Group has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14 % return per unit of volatility over the last 3 months. By analyzing MiMedx's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please exercise MiMedx's risk adjusted performance of 0.1306, and Mean Deviation of 1.9 to check out if our risk estimates are consistent with your expectations.
MiMedx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
MiMedx |
Sharpe Ratio = 0.1422
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | MDXG | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.59 actual daily | 31 69% of assets are more volatile |
Expected Return
0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average MiMedx is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MiMedx by adding it to a well-diversified portfolio.
Related Headline
Monte Rosa Headline on 19th of December 2024
Monte Rosa Therapeutics Lowered to Equal Weight Rating by We... by thelincolnianonline.com
Monte Rosa Therapeutics was downgraded by investment analysts at Wells Fargo Company from an overweight rating to an equal weight rating in a research note issued on Thursday,Finviz reports. They presently have a 11.00 target price on the stock, down from their previous target price of 14.00. Wells Fargo
MiMedx Valuation on December 19, 2024
It is possible to determine the worth of MiMedx on a given historical date. On December 19, 2024 MiMedx was worth 9.14 at the beginning of the trading date compared to the closed value of 9.08. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of MiMedx stock. Still, in general, we apply an absolute valuation method to find MiMedx's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of MiMedx where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against MiMedx's related companies.
Open | High | Low | Close | Volume | |
9.59 | 9.60 | 9.11 | 9.13 | 887,801 | |
12/19/2024 | 9.14 | 9.21 | 9.00 | 9.08 | 503,471 |
8.94 | 9.22 | 8.93 | 9.10 | 1,635,769 |
Backtest MiMedx | | | MiMedx History | | | MiMedx Valuation | Previous | Next |
MiMedx Trading Date Momentum on December 19, 2024
On December 20 2024 MiMedx Group was traded for 9.10 at the closing time. The top price for the day was 9.22 and the lowest listed price was 8.93 . The trading volume for the day was 1.6 M. The trading history from December 20, 2024 was a factor to the next trading day price rise. The trading delta at closing time against the next closing price was 0.22% . The trading delta at closing time against the current closing price is 3.41% . |
MiMedx Group Fundamentals Correlations and Trends
By evaluating MiMedx's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among MiMedx's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. MiMedx financial account trend analysis is a perfect complement when working with valuation or volatility modules.About MiMedx Stock history
MiMedx investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MiMedx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MiMedx Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MiMedx stock prices may prove useful in developing a viable investing in MiMedx
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. Mimedx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 811 people.
MiMedx Stock Technical Analysis
MiMedx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
MiMedx Period Price Range
Low | January 30, 2025
| High |
0.00 | 0.00 |
MiMedx Group cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
MiMedx January 30, 2025 Market Strength
Market strength indicators help investors to evaluate how MiMedx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MiMedx shares will generate the highest return on investment. By undertsting and applying MiMedx stock market strength indicators, traders can identify MiMedx Group entry and exit signals to maximize returns
MiMedx Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for MiMedx's price direction in advance. Along with the technical and fundamental analysis of MiMedx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MiMedx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1306 | |||
Jensen Alpha | 0.5251 | |||
Total Risk Alpha | 0.1939 | |||
Sortino Ratio | 0.2104 | |||
Treynor Ratio | (2.84) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |